Zydus Lifesciences Limited — Updates, 26-11-2025: Press Release
26-11-2025 | 12:24 pm
26-11-2025 | 12:24 pm
Zydus Lifesciences has formed an exclusive licensing and commercialization agreement with RK Pharma for a novel oncology supportive care injectable product for the US market. RK Pharma will manufacture, while Zydus handles commercialization. This targets a significant market opportunity.
No comments yet. Be the first to comment!
